1. Analisi di budget impact del biosimilare di etanercept: lo scenario italiano. (24th April 2018) Authors: Ravasio, Roberto; Girolomoni, Giampiero; Gorla, Roberto Journal: Global & regional health technology assessment Issue: Volume 2018(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Analisi di Budget Impact di Ticagrelor nel Trattamento di Prevenzione in Pazienti con Sindrome Coronarica Acuta. Issue 1 (2017) Authors: Perna, Gian Piero; Ravasio, Roberto; Ricciardelli, Antonio Journal: Global & regional health technology assessment Issue: Volume 4:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Analisi Economica Associata all'utilizzo Di Due Test (Real-Time PCR-Based) per Valutare La Determinazione Dell'HCV-RNA Nei Pazienti HCV Genotipo 1 in Trattamento Con Duplice o Triplice Terapia. Issue 1 (2017) Authors: Aghemo, Alessio; Lunghi, Giovanna; Ravasio, Roberto; Torresani, Erminio; Dionisi, Matteo; Paolini, Davide; Colombo, Massimo Journal: Global & regional health technology assessment Issue: Volume 4:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical and Economic Management of Uterine Fibroids: The Point of View of a Decision Makers Board. Issue 3 (November 2016) Authors: Di Carlo, Costantino; Maiorana, Antonio; Poidomani, Ignazia; Ravasio, Roberto; Vercellone, Adriano Journal: Global & regional health technology assessment Issue: Volume 3:Issue 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Cost per responder for ixekizumab and other biologic drugs approved for the treatment of moderate-to-severe plaque psoriasis in Italy. (January 2019) Authors: Ravasio, Roberto; Antonelli, Silvia; Maiorino, Alessia; Costanzo, Antonio; Losi, Serena Journal: Global & regional health technology assessment Issue: Volume 2019(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cost-Effectiveness Analysis of Triptorelin versus Leuprolide in the Treatment of Advanced Prostate Cancer. Issue 3 (November 2016) Authors: Ravasio, Roberto Journal: Global & regional health technology assessment Issue: Volume 3:Issue 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Difficulties and Challenges in the Management of Market Access for Innovative Oncological Therapies. Issue 3 (November 2016) Authors: Zaniboni, Alberto; Ravasio, Roberto Journal: Global & regional health technology assessment Issue: Volume 3:Issue 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Economical Evaluation of the Sustain Program for the Out-of-Hospital Administration of Abatacept for Rheumatoid Arthritis. Issue 3 (November 2016) Authors: Muratore, Maurizio; Migliore, Alberto; d'Onofrio, Francesca; Perricone, Roberto; Bucci, Romano; Scioscia, Crescenzio; Gattamelata, Angelica; Sensi, Felice; Minisola, Giovanni; Vullo, Marina Lo; Famà, Maria Iolanda; Ravasio, Roberto Journal: Global & regional health technology assessment Issue: Volume 3:Issue 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and Treatment Costs of Monotherapy with bDMARDs in the Treatment of Rheumatoid Arthritis in Patients Intolerant to or Inappropriate to Continue Treatment with Methotrexate. Issue 8 (August 2016) Authors: Batticciotto, Alberto; Ravasio, Roberto; Riva, Marta; Sarzi-Puttini, Piercarlo Journal: Advances in therapy Issue: Volume 33:Issue 8(2016) Page Start: 1360 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Il Costo Degli Eventi Avversi Associati ad Afatinib, Erlotinib e Gefitinib Nel Trattamento del Tumore del Polmone non a Piccole Cellule con Mutazione EGFR. Issue 1 (2017) Authors: Favaretto, Adolfo; Grossi, Francesco; Morabito, Alessandro; Ravasio, Roberto Journal: Global & regional health technology assessment Issue: Volume 4:Issue 1(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗